2Kruger C,Lahm T,Zugck C, et al. Heart rate variability enhances the prognostic value of established parameters inpatients with congestive heart failure[J]. Zeitschrift fur Kardiologie, 2002,91 (12) :1003-1011.
3Witham MD, Gillespie ND, Struthers AD. Age is not a significant risk factor for failed trail of beta-blocker therapy in older patients with chronic heart failure [J]. Age Ageing, 2004,33(5) :467-472.
4Hosoya K, Ishimitsu T. Protection of the cardiovascular system by imidapril,a versatile angiotensin-convcrting enzyme inhibitor [J].Cardiovase Drug Rev, 2002,20 (2) : 93- 110.
7Swedlberg K,Cleland J, Dargie H,et al. Guidelines for the diagnosis and treatment of chronic heart failure:executive summary(update 2005):The task force for the diagnosis and treatment of chronie heart failure of the european society of cardiology [J]. Eur Heart J, 2005,26 (11) : 1115- 1140.
8Arnold JM, Liu P, Demers C, et al. Canadian cardiovascular society consensus conference recommendations on heart failure 2006:diagnosis and management[J]. Can J Cardiol, 2006,22(1) :23-45.
4Charlap S, Lichstein E,William H, et al. Adrenergic blocking drug in the treatment of congestive heart failure[J]. Med Cli North Atn,2001,73(27) :373.
5Caruso R, De Chiara B, Campolo J, et al. Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure[J]. Clin Biochem, 2013, 46(1-2) : 94.
6Kaneshiro T, Suzuki H, Yamada S, et al. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients[J]. Int Heart J, 2012, 53(4): 249.
7Ahmet I, Morrell C, Lakatta E G, et al. Therapeutic efficacy of a combination of a betal-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a betal-AR blocker plus angiotensin-converting enzyme inhibitor[J]. J Pharmacol Exp Ther, 2009. 331(1): 178.
8Smilde T D, van Veldhuisen D J, van den Berg M P. Prog- nostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure[J]. Clin Res Cardiol, 2009, 98(4) : 233.
9Caruso R, De Chiara B, Campolo J, et al. Neopterin levels are independently associated with cardiac remodeling in pa- tients with chronic heart failure[J]. Clin Biochem, 2013, 46 (1/2). 94.
10Huang W Y, Sun M, Zhou H Y, et al. Effect of the poly- morphism of the an_giotensin- converting enzyme gene on the drug treatment in patients with chronic heart failure[J]. Jour- nal of Central South University of Technology, 2004, 29(6) : 686.
